Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Anemia

Free Subscription Articles published in Ann Hematol Retrieve available abstracts of 205 articles: HTML format

Single Articles

January 2026
1. GEORGE B, Ross CR, Damodar S, Seth T, et al
   A meta-analysis of immunosuppressive and Pharmacological therapies in aplastic anaemia with and without Indigenous equine antithymocyte globulin (eATG).
   Ann Hematol. 2026;105:52.
   PubMed     Abstract available
   
   
   
2. HALKES CJM, Koster EAS, Bogers EJM, Heubel-Moenen FCJI, et al
   Anti-thymocyte globulin-based treatment frequently leads to enduring treatment success in both old and young adult patients with aplastic anaemia: a real-world analysis from the Dutch aplastic anaemia registry.
   Ann Hematol. 2026;105:51.
   PubMed     Abstract available
   
   
   
3. IORI AP, De Vivo A, Di Bona E, Caocci G, et al
   Real life use of ravulizumab in Italian patients with paroxysmal nocturnal hemoglobinuria: evidence from the REACTION observational study.
   Ann Hematol. 2026;105:50.
   PubMed     Abstract available
   
   
   
4. ALLARD PN, Kulozik AE, Kunz JB
   Case series: a rare dominant form of beta-thalassemia successfully treated by luspatercept.
   Ann Hematol. 2026;105:45.
   PubMed     Abstract available
   
   
   
5. HU K, Cheng Y, Xiao G, Shen X, et al
   Mendelian randomization analysis of immune cell subsets and inflammatory cytokines in aplastic anaemia.
   Ann Hematol. 2026;105:36.
   PubMed     Abstract available
   
   
   
6. BISIOU S, Lobbes H, Palassin P, Allouchery M, et al
   Immune checkpoint inhibitor-induced pure red cell aplasia: a nationwide retrospective case series and literature review.
   Ann Hematol. 2026;105:38.
   PubMed     Abstract available
   
   
   
7. XING L, Yang W, Fan H, Li J, et al
   Cyclosporine related adverse events in aplastic anemia patients treated with immunosuppressive therapy.
   Ann Hematol. 2026;105:27.
   PubMed     Abstract available
   
   
   
8. JIA X, Zheng R, Hong Y, Ge H, et al
   Luspatercept for the treatment of transfusion-dependent non-severe aplastic anemia.
   Ann Hematol. 2026;105:6.
   PubMed    
   
   
   
9. OTHMANI M, Amri Y, Jouini Y, Ouali F, et al
   Vitamin D deficiency in sickle cell disease: a neglected comorbidity in Tunisia.
   Ann Hematol. 2026;105:2.
   PubMed     Abstract available
   
   
   December 2025
10. BENITO SF, Abio M, Bardon-Cancho EJ, Nieto JM, et al
    Importance of the 3'UTR region in globin synthesis: identification of two novel HBA1 mutations causing alpha-Thalassemia.
    Ann Hematol. 2025;104:6169-6174.
    PubMed     Abstract available
    
    
    
11. CHIBUIFE EC, Chisom Adaobi NE, Odini F, Deepika HD, et al
    Can platelet to neutrophil ratio (PNR) serve as a viable alternative tool for monitoring sickle cell disease patients on hydroxyurea in low income countries?
    Ann Hematol. 2025;104:6161-6168.
    PubMed     Abstract available
    
    
    
12. LIU HL, Huang WT
    Hemoglobin suresnes combined with alpha(0)-thalassemia: Diagnostic challenges and insights from trio-based whole exome sequencing.
    Ann Hematol. 2025;104:6391-6394.
    PubMed     Abstract available
    
    
    
13. YE C, Zhou X, Wei Y, Zhao Y, et al
    A direct multiplex isothermal amplification-reverse dot blot hybridization system for beta-thalassemia diagnosis.
    Ann Hematol. 2025;104:6147-6159.
    PubMed     Abstract available
    
    
    November 2025
14. GE Y, Yang Y, Luo Y, Xian L, et al
    Characterization and risk assessment of HbF elevation in non-thalassemia hematologic disease patients in Guangdong region.
    Ann Hematol. 2025;104:5647-5654.
    PubMed     Abstract available
    
    
    
15. FARES R, Bakr S, El-Hamid RGA, Abdelaleem OO, et al
    Circulating miR-145-5p and miR-133a-3p in pediatric sickle cell disease: biomarker potential for vaso-occlusive crises and disease activity.
    Ann Hematol. 2025;104:5625-5633.
    PubMed     Abstract available
    
    
    
16. FUREDER W, Granser S, Repa A, Farr A, et al
    Ravulizumab exposure in early pregnancy.
    Ann Hematol. 2025;104:6081-6084.
    PubMed     Abstract available
    
    
    October 2025
17. BOSQUES L, Modepalli S, Nagarajan A, Tang C, et al
    Codanin-1, defective in congenital dyserythropoietic anemia I (CDA-I), regulates erythroid differentiation.
    Ann Hematol. 2025 Oct 1. doi: 10.1007/s00277-025-06540.
    PubMed     Abstract available
    
    
    
18. WANG Z, Yu XH, Liang JL, Lai BR, et al
    Establishment of reference interval (RI) for G6PD/6PGD ratio in adults from Yangjiang, China.
    Ann Hematol. 2025;104:4959-4968.
    PubMed     Abstract available
    
    
    
19. KOTILA T, Aworanti O, Akunwata C, Ogundeji P, et al
    Haemoglobin variants in nigeria: real-world data from a point-of-care device.
    Ann Hematol. 2025;104:5055-5061.
    PubMed     Abstract available
    
    
    
20. NKYA S, Mahawi I, Shungu R, Nzunda C, et al
    Early-life clinical and hematological profiles: a comparative study of children with and without sickle cell disease in the first three years of life.
    Ann Hematol. 2025;104:4949-4957.
    PubMed     Abstract available
    
    
    
21. WU J, Wang L, Jin Z, Ren L, et al
    Epidemiological study of thalassemia in the Buyi population of Qiannan Prefecture, Guizhou Province, China based on third-generation sequencing.
    Ann Hematol. 2025;104:5037-5045.
    PubMed     Abstract available
    
    
    
22. KOFFI JFK, Botti RP, Ayemou R, N'dri AAC, et al
    Morbidity and mortality of sickle cell disease in Cote d'Ivoire.
    Ann Hematol. 2025;104:5019-5025.
    PubMed     Abstract available
    
    
    
23. WANG X, Ding Y, Huang Z, Huang J, et al
    The diagnosis and clinical characterization of -alpha3.7/--SEA thalassemia patients: two cases report.
    Ann Hematol. 2025;104:5501-5506.
    PubMed     Abstract available
    
    
    
24. WIRAHMADI A, Rahmartani LD, Wahidiyat PA
    Revisiting hepatitis B vaccination in children with transfusion-dependent thalassemia.
    Ann Hematol. 2025;104:5011-5017.
    PubMed     Abstract available
    
    
    September 2025
25. YANG C, Huang J, Yang K, Wei C, et al
    Haploidentical hematopoietic stem cell transplantation for the treatment of congenital dyserythropoietic anemia combined with thalassemia: a report of two cases.
    Ann Hematol. 2025 Sep 26. doi: 10.1007/s00277-025-06615.
    PubMed     Abstract available
    
    
    
26. BIRSIN Z, Salihoglu A, Tokdil KO, Pirdal BZ, et al
    Is splenectomy one of the contributory factors to pulmonary hypertension? An analysis of splenectomized hemolytic anemia and immune thrombocytopenia patients.
    Ann Hematol. 2025 Sep 9. doi: 10.1007/s00277-025-06583.
    PubMed     Abstract available
    
    
    
27. NAGEL SN, Brintrup J, Ghannam Y, Stallmach A, et al
    Combined heterozygosity for the highly unstable variant hemoglobin Taybe, and alpha-thalassemia as a rare cause of hemolytic anemia.
    Ann Hematol. 2025 Sep 9. doi: 10.1007/s00277-025-06578.
    PubMed    
    
    
    
28. MAKALO L, Manka M, Perez OR, Joof S, et al
    Severity patterns and predictors of sickle cell anaemia among Gambian children: A cross-sectional analysis.
    Ann Hematol. 2025;104:4429-4436.
    PubMed     Abstract available
    
    
    
29. GONG Y, Chai X, Liu X, Zhang Y, et al
    Comprehensive analysis of the clinical feature, myeloid neoplasm-related gene mutation profiles and T cell diversity acquired pure red cell aplasia.
    Ann Hematol. 2025;104:4411-4427.
    PubMed     Abstract available
    
    
    
30. ABBAS S, Khan MO, Arif A, Majid H, et al
    Framework for the comprehensive screening for endocrine disorders in patients with transfusion-dependent thalassemia in low-resource settings.
    Ann Hematol. 2025;104:4391-4409.
    PubMed     Abstract available
    
    
    
31. YU L, Xu G, Chen Z, Lin K, et al
    Genetic analysis of thalassemia in putian: comparative insights into mutation spectra with other global regions.
    Ann Hematol. 2025;104:4465-4476.
    PubMed     Abstract available
    
    
    
32. WEI R, Qiu D, Zeng X
    Genetic biomarkers and crucial cell subsets of iron metabolism in Beta-Thalassemia: insights from bioinformatics and experimental validation.
    Ann Hematol. 2025;104:4369-4384.
    PubMed     Abstract available
    
    
    
33. BROGHAMMER S, Gagesch M, Wieczorek M, Kressig RW, et al
    Hemoglobin levels and frailty status in generally healthy and active community-dwelling adults age 70 years and older in the three-year DO-HEALTH study.
    Ann Hematol. 2025;104:4437-4445.
    PubMed     Abstract available
    
    
    
34. BEZIRGIANNIDOU Z, Stamatiou I, Theodoridis TM, Kontekaki E, et al
    Ravulizumab stabilizes life-threating intravascular hemolysis following delayed hemolytic transfusion reaction due to alloantibodies anti-e and anti-Jka: the first successful administration.
    Ann Hematol. 2025;104:4849-4854.
    PubMed     Abstract available
    
    
    
35. D'ADDIO A, Rondoni M, Salvucci M, Marconi G, et al
    PNH clones prevalence study in ph-negative myeloproliferative neoplasms: a multicenter Italian study.
    Ann Hematol. 2025;104:4487-4494.
    PubMed     Abstract available
    
    
    
36. HUANG L, Li M, Niu T, Chang H, et al
    Anti-plasma cell therapy in patients with monoclonal gammopathy-associated refractory pure red cell aplasia: A report of three cases and literature review.
    Ann Hematol. 2025;104:4837-4841.
    PubMed     Abstract available
    
    
    
37. ALKINDI S, Al Subhi A, Pathare A
    Rapid withdrawal of voxelotor can precipitate sickle cell disease related crisis.
    Ann Hematol. 2025;104:4855-4857.
    PubMed     Abstract available
    
    
    August 2025
38. ZHANG X, Xie J, Wang H, Li J, et al
    Analysis of fecal microbiome in Chinese patients with non-severe aplastic anemia.
    Ann Hematol. 2025 Aug 19. doi: 10.1007/s00277-025-06459.
    PubMed     Abstract available
    
    
    
39. YE L, Zhang L, Zhang D, Zhao X, et al
    Somatic mutations and the efficacy of immunosuppressive therapy in severe/very severe aplastic anemia and transfusion-dependent nonsevere aplastic anemia.
    Ann Hematol. 2025 Aug 7. doi: 10.1007/s00277-025-06393.
    PubMed     Abstract available
    
    
    
40. SHI L, Yan X, Xia Y, Zhao Y, et al
    Beyond transfusions and transplants: genomic innovations rewriting the narrative of thalassemia.
    Ann Hematol. 2025;104:3963-3980.
    PubMed     Abstract available
    
    
    
41. OZAHATA MC, Gomes I, Oliveira BA, Park M, et al
    Genetic modifiers of frequent vaso-occlusive hospitalizations among individuals with sickle cell disease (SCD).
    Ann Hematol. 2025;104:4029-4035.
    PubMed     Abstract available
    
    
    
42. LI H, Gu Y, Zhao X, Ding G, et al
    Comparative longitudinal analysis of pulmonary function post-pediatric Allo-HSCT: benign vs. malignant diseases and early predictors.
    Ann Hematol. 2025;104:4201-4211.
    PubMed     Abstract available
    
    
    
43. WARNCKE K, Nero A, Sarode R, Adkins BD, et al
    Hyperhemolysis in a sickle cell disease patient in pregnancy.
    Ann Hematol. 2025;104:4245-4249.
    PubMed     Abstract available
    
    
    
44. PEDERSEN TH, Tjonnfjord E, Korkama ES, Vikman M, et al
    The incidence of paroxysmal nocturnal hemoglobinuria cell clones in the Nordic countries.
    Ann Hematol. 2025;104:4277-4283.
    PubMed     Abstract available
    
    
    
45. NIKOLAIDIS CG, Gyriki D, Gogos DG, Stavropoulou E, et al
    Sickle cell beta-thalassemia diagnosed at age 40: a case report.
    Ann Hematol. 2025;104:4229-4236.
    PubMed     Abstract available
    
    
    
46. WANG Y, Liu T, Wang W, Li Y, et al
    Three novel heterozygous ANK1 loss-of-function variants cause hereditary spherocytosis in Chinese families.
    Ann Hematol. 2025;104:4045-4056.
    PubMed     Abstract available
    
    
    July 2025
47. JANG JH, Mitani K, Tomiyama Y, Miyazaki K, et al
    Predictive factors of romiplostim response in patients with refractory aplastic anemia: data from two clinical trials.
    Ann Hematol. 2025 Jul 1. doi: 10.1007/s00277-025-06337.
    PubMed     Abstract available
    
    
    
48. CHEN R, Zhang R, He X, Zhang Q, et al
    Factors influencing prenatal diagnosis of deletional hemoglobin H disease in thalassemia prevention and control program, Southern China.
    Ann Hematol. 2025;104:3567-3574.
    PubMed     Abstract available
    
    
    
49. UEDA Y, Obara N, Ueno S, Sakurai M, et al
    Treatment burden in patients with paroxysmal nocturnal hemoglobinuria: an in-depth interview survey.
    Ann Hematol. 2025;104:3575-3584.
    PubMed     Abstract available
    
    
    
50. LIU H, Du Y, Yang Y, Cui D, et al
    Identification of a novel complex variant in a patient involving the alpha-globin gene cluster by third-generation sequencing.
    Ann Hematol. 2025;104:3619-3629.
    PubMed     Abstract available
    
    
    
51. LI Y, Jiang H, Luo L, Mei H, et al
    Immunotherapy-associated hemostatic abnormalities: bleeding and thrombotic complications.
    Ann Hematol. 2025;104:3537-3551.
    PubMed     Abstract available
    
    
    
52. ENGOLE YM, Makulo JRR, Bukabau JB, Nlandu YM, et al
    Genotype-dependent albuminuria in adult sickle cell disease in Kinshasa.
    Ann Hematol. 2025;104:3585-3595.
    PubMed     Abstract available
    
    
    
53. ZHU G, Ren Y, Wang L, Wang S, et al
    Assessing serum thrombopoietin for enhanced diagnosis of ITP, AA, and MDS using machine learning: A retrospective cohort study.
    Ann Hematol. 2025;104:3631-3645.
    PubMed     Abstract available
    
    
    June 2025
54. ZHANG S, Ji Q, Gao L, Wang Q, et al
    Efficacy and safety of rabbit ATLG and ATG in allogeneic hematopoietic stem cell transplantation for children with acquired severe aplastic anemia.
    Ann Hematol. 2025 Jun 19. doi: 10.1007/s00277-025-06461.
    PubMed     Abstract available
    
    
    
55. CHAIPOKAM J, Rojnuckarin P
    Good response to oxymetholone in adult aplastic anemia.
    Ann Hematol. 2025 Jun 14. doi: 10.1007/s00277-025-06460.
    PubMed     Abstract available
    
    
    
56. AMRI Y, Fredj SH, Dabboubi R, Othmani R, et al
    Revealing silent alpha-thalassemia: characterization of novel HBA1 deletion and missense mutation in Tunisian families.
    Ann Hematol. 2025;104:3173-3182.
    PubMed     Abstract available
    
    
    
57. LIN MH, Wang YJ, Zhang YY, Cheng YF, et al
    The outcomes of second haploidentical donor transplantation for graft failure in patients with severe aplastic anaemia.
    Ann Hematol. 2025;104:3469-3476.
    PubMed     Abstract available
    
    
    May 2025
58. PARK S, Kim HK
    Epidemiologic sequential analysis of pure red blood cell aplasia and T-cell large granular lymphocyte leukemia in Korea.
    Ann Hematol. 2025 May 22. doi: 10.1007/s00277-025-06406.
    PubMed     Abstract available
    
    
    
59. EFOBI C, Ukpai N, Eze OE, Basil B, et al
    Platelet-to-Neutrophil ratio as a predictor of risk of complications in sickle cell disease: a valuable insight for resource-limited settings.
    Ann Hematol. 2025;104:2663-2669.
    PubMed     Abstract available
    
    
    
60. MAHABHOL C, Yothindamrongkul L, Nuntanajaroenkul N, Nawasod P, et al
    Genetic polymorphism of novel SNP rs5006884 in OR51B6 and SNP rs4499252 in AHSP among transfusion-dependent and non-transfusion-dependent beta-thalassemia/Hb E patients in Thailand: a multivariate analysis of clinical and genetic polymorphism.
    Ann Hematol. 2025;104:2653-2661.
    PubMed     Abstract available
    
    
    
61. KWON YD, Hong KT, Lee J, Sunwoo Y, et al
    Clinical usefulness of next-generation sequencing-based target gene sequencing in diagnosis of inherited bone marrow failure syndrome.
    Ann Hematol. 2025;104:2693-2706.
    PubMed     Abstract available
    
    
    
62. AN N, Bian K, Li C
    Alemtuzumab for haematological malignancies.
    Ann Hematol. 2025;104:2593-2603.
    PubMed     Abstract available
    
    
    April 2025
63. TAYLOR KJ, Singer S, Langemeijer S, Kelly RJ, et al
    What are the most important quality of life domains for patients with aplastic anemia and paroxysmal nocturnal hemoglobinuria?
    Ann Hematol. 2025 Apr 29. doi: 10.1007/s00277-025-06377.
    PubMed    
    
    
    
64. LIU X, Chai X, Yu Q, Wang W, et al
    Clinical features and outcomes in large granular lymphocyte leukemia - associated pure red cell aplasia with STAT3 mutation.
    Ann Hematol. 2025 Apr 23. doi: 10.1007/s00277-025-06371.
    PubMed     Abstract available
    
    
    
65. CHEN T, Song J, Xing L, Chen J, et al
    From severe aplastic anemia with TERT variant to Wilson disease - associations or not.
    Ann Hematol. 2025 Apr 21. doi: 10.1007/s00277-025-06370.
    PubMed     Abstract available
    
    
    
66. LI J, Shi Y, Zhang B, Yang W, et al
    The efficacy of immunosuppressive therapy with or without thrombopoietin receptor agonist in elderly patients with severe aplastic anemia.
    Ann Hematol. 2025 Apr 7. doi: 10.1007/s00277-025-06335.
    PubMed     Abstract available
    
    
    
67. RAMESH M, Fakhari-Tehrani Y, Deenadayalan V, Padhi P, et al
    Impact of protein-energy malnutrition on outcomes of patients with sickle cell disease: an analysis of the National inpatient sample.
    Ann Hematol. 2025;104:2171-2177.
    PubMed     Abstract available
    
    
    
68. MANNING JE, Ciantar E, Griffin M, Kelly RJ, et al
    Paroxysmal nocturnal haemoglobinuria in pregnancy-a systematic review with meta analysis.
    Ann Hematol. 2025;104:2517-2525.
    PubMed     Abstract available
    
    
    
69. AL-AWADHI A, Alwehaidah MS, Al-Sabaan K, Al-Ajmi N, et al
    Assessment of ferritin and hepcidin levels in splenectomised and non-splenectomised beta-thalassemia major patients and exploring a potential correlation with von Willebrand factor and ADAMTS-13.
    Ann Hematol. 2025;104:2229-2238.
    PubMed     Abstract available
    
    
    
70. YUSUP M, He G, Qin Y, Tuerxun N, et al
    Efficacy and influencing factors of immunosuppressive therapy for pure red cell aplasia: meta-analysis and systematic review.
    Ann Hematol. 2025;104:2189-2206.
    PubMed     Abstract available
    
    
    
71. RODRIGUEZ NG, Franciss G, Perez E, Maryam Z, et al
    Understanding the role of asthma in acute chest syndrome: a comparative analysis of patients with and without asthma.
    Ann Hematol. 2025;104:2179-2187.
    PubMed     Abstract available
    
    
    
72. JIANG F, Wu J, Yang M, Chen X, et al
    An unusual transfusion-dependent hemoglobin H disease caused by a novel complex inverted duplication involving the alpha-globin regulatory elements and alpha-thalassemia--SEA deletion.
    Ann Hematol. 2025;104:2529-2535.
    PubMed     Abstract available
    
    
    March 2025
73. STEMPEL JM, Wang R, Lee AI, Zeidan AM, et al
    Initial management of patients with acquired aplastic anemia in the United States: results from a large national claims database.
    Ann Hematol. 2025 Mar 19. doi: 10.1007/s00277-025-06307.
    PubMed     Abstract available
    
    
    
74. ROMANELLO KS, da Silva JPMO, Torres FF, Teixeira KKL, et al
    Unraveling the multifaceted roles of peroxiredoxins in sickle cell anemia: implications in redox and inflammation adaptations.
    Ann Hematol. 2025 Mar 14. doi: 10.1007/s00277-025-06294.
    PubMed     Abstract available
    
    
    
75. LIU T, Fillbrunn M, Zhang S, Chen J, et al
    Treatment patterns and healthcare resource utilization in ruxolitinib-treated patients with myelofibrosis with and without anemia: a real-world analysis.
    Ann Hematol. 2025 Mar 12. doi: 10.1007/s00277-025-06279.
    PubMed     Abstract available
    
    
    
76. REKAYA S, Ben Fraj I, Hamdi R, Ben Taieb A, et al
    Sideroblastic anemia in children: challenges in diagnosis and management in three cases.
    Ann Hematol. 2025 Mar 5. doi: 10.1007/s00277-025-06266.
    PubMed     Abstract available
    
    
    
77. KAWAKAMI T, Kawakami F, Matsuzawa S, Yamane T, et al
    Mutational heterogeneities in STAT3 and clonal hematopoiesis-related genes in acquired pure red cell aplasia.
    Ann Hematol. 2025;104:1471-1479.
    PubMed     Abstract available
    
    
    
78. KEESARI PR, Vegivinti CTR, Rajamanuri M, Mustafa A, et al
    Racial disparities in cardiovascular manifestations among patients with sickle cell trait: analysis of national inpatient sample data (2016-2020).
    Ann Hematol. 2025;104:1501-1506.
    PubMed     Abstract available
    
    
    
79. LAI D, Chen D, Chen X, Zhou R, et al
    Effect of major ABO blood group mismatched HSCT on blood transfusion and clinical outcomes in AA patients.
    Ann Hematol. 2025;104:1931-1947.
    PubMed     Abstract available
    
    
    
80. KARGAR M, Kaydani GA, Keikhaei B, Saki N, et al
    Association between HLA-DRB1*04, HLA-DQB1*03, and HLA-DQB1*06 with alloimmunization in transfusion-dependent patients with thalassemia: the first case-control study in Iran.
    Ann Hematol. 2025;104:1493-1499.
    PubMed     Abstract available
    
    
    
81. BODE AL, Borja-Montes OF, Quazi MA, Mumtaz A, et al
    Sickle cell disease and opioid overdose outcomes in the United States: a nationwide analysis.
    Ann Hematol. 2025;104:1551-1561.
    PubMed     Abstract available
    
    
    
82. LI Y, Feng Y, Wei Y, Huang J, et al
    The impact of various types of alpha-thalassemia on perinatal complications and pregnancy outcomes in pregnant women.
    Ann Hematol. 2025;104:1541-1550.
    PubMed     Abstract available
    
    
    
83. HUANG L, Zhang Q, Ye Y, Long Y, et al
    Rapid detection of genetic modifiers of beta-thalassemia based on MALDI-TOF MS.
    Ann Hematol. 2025;104:1481-1492.
    PubMed     Abstract available
    
    
    
84. SCHNEDL WJ, Leixner G, Voill-Glaninger A, Michaelis S, et al
    Combined heterozygosity for hemoglobin Pakse, alpha-thalassemia and for hemoglobin E, beta- thalassemia ? first appearance in Europe.
    Ann Hematol. 2025;104:2059-2064.
    PubMed     Abstract available
    
    
    
85. ALHARBI M, Bawek S, Lund I, Glenn ST, et al
    Rare case of pure red cell aplasia secondary to smoldering multiple myeloma successfully treated with daratumumab - case report and review of the literature.
    Ann Hematol. 2025;104:2027-2034.
    PubMed     Abstract available
    
    
    
86. TAN Z, Zhang X, Feng J, Zhao Y, et al
    Hematopoietic stem cell transplantation and immunosuppressive therapy: implications of clonal haematopoiesis.
    Ann Hematol. 2025;104:1877-1886.
    PubMed     Abstract available
    
    
    February 2025
87. CHEN L, Wei X, Zheng C, Liu X, et al
    Novel AK-1 gene variants combined with thalassemia causing rare hereditary non-spherocytic hemolytic anemia in a Chinese family.
    Ann Hematol. 2025 Feb 28. doi: 10.1007/s00277-025-06289.
    PubMed     Abstract available
    
    
    
88. YAN Q, Zhang Y, Wei L, Liu X, et al
    Assessment of anemia recovery using peripheral blood smears by deep semi-supervised learning.
    Ann Hematol. 2025 Feb 21. doi: 10.1007/s00277-025-06254.
    PubMed     Abstract available
    
    
    
89. LIU A, Jacobs-McFarlane C, Sebastiani P, Glassberg J, et al
    Plasma free hemoglobin is associated with LDH, AST, total bilirubin, reticulocyte count, and the hemolysis score in patients with sickle cell anemia.
    Ann Hematol. 2025 Feb 19. doi: 10.1007/s00277-025-06253.
    PubMed     Abstract available
    
    
    
90. CHEN X, Yu Q, Qin C, Zhang Y, et al
    Combining immunosuppressive therapy with low dosage eltrombopag in Chinese patients with severe aplastic anemia: mild aggravation of hepatic injury.
    Ann Hematol. 2025 Feb 5. doi: 10.1007/s00277-025-06210.
    PubMed     Abstract available
    
    
    
91. AMMAR M, Kmiha S, Maalej M, Felhi R, et al
    Identification of a novel truncated pathogenic variant in PUS1 gene in two siblings of consanguineous Tunisian family: intrafamilial phenotypic variability related to mtDNA copy number.
    Ann Hematol. 2025;104:943-952.
    PubMed     Abstract available
    
    
    
92. WU T, Ren Z, Liu X, Xing Z, et al
    Systematic identification and validation of ceRNA-driven regulatory mechanisms in pediatric beta-Thalassemia major.
    Ann Hematol. 2025;104:963-972.
    PubMed     Abstract available
    
    
    
93. ARLET JB, Bernaudin F, Deme-Ly I, Coulibaly B, et al
    Use of hydroxyurea in French-speaking Sub-Saharan Africa.
    Ann Hematol. 2025;104:937-941.
    PubMed     Abstract available
    
    
    
94. LIU Y, Liu M, He X, Yang L, et al
    Molecular landscape of CD8(+) T cells in pure red cell aplasia.
    Ann Hematol. 2025;104:953-961.
    PubMed     Abstract available
    
    
    
95. MAHADEVIA H, Ponvilawan B, Madan U, Sharma P, et al
    A review on disease modifying pharmacologic therapies for sickle cell disease.
    Ann Hematol. 2025;104:881-893.
    PubMed     Abstract available
    
    
    
96. XING L, Liang W, Li Y, Xiao J, et al
    Concurrent inhibited erythropoiesis in a case of VEXAS syndrome.
    Ann Hematol. 2025;104:1255-1258.
    PubMed     Abstract available
    
    
    
97. RIEDL J, Pfeilstocker M, Farr A, Hausler G, et al
    Management of paroxysmal nocturnal hemoglobinuria with low-level hemolysis in pregnancy- a report of two cases.
    Ann Hematol. 2025;104:1249-1253.
    PubMed     Abstract available
    
    
    
98. GOLDSCHMIDT V, Apodaca EI, Galvez KM, Wannesson B, et al
    Clinical characteristics and management of paroxysmal nocturnal haemoglobinuria in Latin America: a narrative review.
    Ann Hematol. 2025;104:867-879.
    PubMed     Abstract available
    
    
    January 2025
99. YANG K, Li Q, Zhuang X, Ma H, et al
    A retrospective analysis of autoimmune hemolytic anemia after allogeneic hematopoietic stem cell transplantation for transfusion-dependent beta-thalassemia: focus on T and B lymphocyte reconstitution.
    Ann Hematol. 2025 Jan 3. doi: 10.1007/s00277-024-06157.
    PubMed     Abstract available
    
    
    
100. KULASEKARARAJ A, Brodsky R, Schrezenmeier H, Griffin M, et al
     Ravulizumab demonstrates long-term efficacy, safety and favorable patient survival in patients with paroxysmal nocturnal hemoglobinuria.
     Ann Hematol. 2025;104:81-94.
     PubMed     Abstract available
     
     
     
101. ZHUANG J, Huang N, Zheng Y, Zhang N, et al
     First clinical and pedigree study of rare HBB: c.316-90 A > G variant in beta-globin gene in Chinese population using third-generation sequencing.
     Ann Hematol. 2025;104:75-80.
     PubMed     Abstract available
     
     
     December 2024
102. JANG T, Burnside RD, Chaffin J, Seifert R, et al
     Severe aplastic anemia with acquired X chromosome clonality as a sole abnormality.
     Ann Hematol. 2024 Dec 31. doi: 10.1007/s00277-024-06166.
     PubMed     Abstract available
     
     
     
103. GAO M, Huang X, Gao S, Wang S, et al
     Similar outcomes between HLA-haploid and matched sibling donor hematopoietic stem cell transplantation: a multicenter, retrospective study and severe aplastic anemia transplant-specific prognostic scoring system.
     Ann Hematol. 2024 Dec 12. doi: 10.1007/s00277-024-06051.
     PubMed     Abstract available
     
     
     
104. PINES M, Kleinert D, Thomas C, Mensah C, et al
     Real-world experience with iron chelation therapy in transfusion-dependent thalassemia: impact of the oral chelators' era.
     Ann Hematol. 2024;103:5229-5234.
     PubMed     Abstract available
     
     
     
105. DAWUDI Y, Azoyan L, Bonjour M, Steichen O, et al
     COVID-19 outcomes among patients with sickle cell disease or sickle cell trait compared to the general population: a systematic review and meta-analyses.
     Ann Hematol. 2024;103:5071-5083.
     PubMed     Abstract available
     
     
     
106. DINGLI D, Rizio AA, Broderick L, LaGasse K, et al
     Health-related quality of life and symptom-specific functional impairment among patients treated with parenterally administered complement inhibitors for paroxysmal nocturnal hemoglobinuria.
     Ann Hematol. 2024;103:5213-5227.
     PubMed     Abstract available
     
     
     
107. FAN L, Cao L, Luo Y, Gao F, et al
     Roxadustat combined with immunosuppressants for treatment of pure red cell aplasia with kidney injury.
     Ann Hematol. 2024;103:5925-5927.
     PubMed     Abstract available
     
     
     
108. MOTTA I, Delbini P, Scaramellini N, Ghiandai V, et al
     Enzyme replacement therapy improves erythropoiesis and iron dysregulation in Gaucher disease.
     Ann Hematol. 2024;103:5113-5121.
     PubMed     Abstract available
     
     
     
109. GUO X, Lin S, Zhang X, Li M, et al
     Integrated metabolomic and microbiome analysis identifies Cupriavidus metallidurans as a potential therapeutic target for beta-thalassemia.
     Ann Hematol. 2024;103:5169-5179.
     PubMed     Abstract available
     
     
     November 2024
110. LOH JB, Ross JM, Musallam KM, Kuo KHM, et al
     Trans-acting genetic modifiers of clinical severity in heterozygous beta-Thalassemia trait.
     Ann Hematol. 2024;103:4437-4447.
     PubMed     Abstract available
     
     
     
111. DE SANTIS M, Tonutti A, Motta F, Todisco G, et al
     Approaches for the diagnosis and treatment of VEXAS syndrome: the importance of clinical suspicion and the use of methotrexate.
     Ann Hematol. 2024;103:4789-4791.
     PubMed     Abstract available
     
     
     October 2024
112. CAHUAPAZA-GUTIERREZ NL
     Aplastic Anemia in the light of the COVID-19 pandemic: infection, vaccination, and pathophysiologic mechanisms.
     Ann Hematol. 2024 Oct 23. doi: 10.1007/s00277-024-06052.
     PubMed     Abstract available
     
     
     
113. DONGERDIYE R, Kedar PS, Saptarshi A, Sampagar A, et al
     Non-syndromic congenital sideroblastic anaemia; phenotype, and genotype of 15 Indian patients.
     Ann Hematol. 2024;103:3987-3998.
     PubMed     Abstract available
     
     
     
114. ZHANG M, Liu M, Yang L, Liu Y, et al
     Increased ferroptosis of erythrocytes is associated with myelodysplastic syndromes.
     Ann Hematol. 2024;103:4009-4020.
     PubMed     Abstract available
     
     
     September 2024
115. CHEN WT, Wang SW, Huang Y, Tang RM, et al
     The effect of hetrombopag combined with conventional treatment on immune function and quality of life in patients with severe aplastic anemia.
     Ann Hematol. 2024 Sep 5. doi: 10.1007/s00277-024-05964.
     PubMed     Abstract available
     
     
     
116. EBEID FSE, Aly NH, Shaheen NM, Abdellatif SMA, et al
     Safety and efficacy of L-Glutamine in reducing the frequency of acute complications among patients with sickle cell disease: A randomized controlled study.
     Ann Hematol. 2024;103:3493-3506.
     PubMed     Abstract available
     
     
     
117. EZZAT EM, Bakr S, Golam RM, Abdelgyed BA, et al
     Adipocyte fatty acid-binding protein (FABP4) as a potential biomarker for predicting metabolically driven low-grade and organ damage in thalassemia syndromes.
     Ann Hematol. 2024;103:3473-3482.
     PubMed     Abstract available
     
     
     
118. JAJODIA E, Menghani H, Arora N, Jitani A, et al
     De-novo ATR-16 syndrome associated with inherited hemoglobin Evanston causing HbH phenotype: a rare occurrence.
     Ann Hematol. 2024;103:3805-3810.
     PubMed     Abstract available
     
     
     
119. PATSOURAKOS D, Aggeli C, Dimitroglou Y, Delicou S, et al
     Speckle tracking echocardiography and beta-thalassemia major. A systematic review.
     Ann Hematol. 2024;103:3335-3356.
     PubMed     Abstract available
     
     
     August 2024
120. SHEN S, Hu Q, Yang C, Jiang Z, et al
     Adding hetrombopag to cyclosporine a improved response of patients with newly diagnosed transfusion-dependent non-severe aplastic anemia.
     Ann Hematol. 2024 Aug 23. doi: 10.1007/s00277-024-05941.
     PubMed    
     
     
     
121. LI X, Shangguan X, Wang H, Wang Q, et al
     Comparison of efficacy of eltrombopag combined with immunosuppression in the treatment of severe aplastic anemia and very severe aplastic anemia: real-world data and evidence.
     Ann Hematol. 2024 Aug 1. doi: 10.1007/s00277-024-05910.
     PubMed     Abstract available
     
     
     
122. IQBAL N, Meghani MA, Khalid W, Ansari AH, et al
     Transcobalamin deficiency - a rare genetic defect in transportation of cobalamin; case report.
     Ann Hematol. 2024;103:3243-3246.
     PubMed     Abstract available
     
     
     
123. FUREDER W, Valent P
     Stable responses to danicopan as add-on to ravulizumab in two patients with paroxysmal nocturnal hemoglobinuria.
     Ann Hematol. 2024;103:3235-3238.
     PubMed    
     
     
     
124. MARCO SANCHEZ JM, Bardon Cancho EJ, Beneitez D, Payan-Pernia S, et al
     Haemoglobinopathies and other rare anemias in Spain: ten years of a nationwide registry (REHem-AR).
     Ann Hematol. 2024;103:2743-2755.
     PubMed     Abstract available
     
     
     
125. YANG J, Shi X, Liu X, Qiao X, et al
     STK10 mutations block erythropoiesis in acquired pure red cell aplasia via impairing ribosome biogenesis.
     Ann Hematol. 2024;103:2711-2720.
     PubMed     Abstract available
     
     
     
126. BHANGU G, Uminski K, Roessner C, Goodyear D, et al
     Dry gangrene in a patient with sickle cell disease on hydroxyurea: a case report.
     Ann Hematol. 2024;103:3277-3279.
     PubMed    
     
     
     
127. LI J, Lv A, Chen M, Xu L, et al
     Activating transcription factor 4 in erythroid development and beta -thalassemia: a powerful regulator with therapeutic potential.
     Ann Hematol. 2024;103:2659-2670.
     PubMed     Abstract available
     
     
     
128. YOUSSRY I, Ayad N
     Sickle cell disease: combination new therapies vs. CRISPR-Cas9 potential and challenges - review article.
     Ann Hematol. 2024;103:2613-2619.
     PubMed     Abstract available
     
     
     
129. KIRTHAN JPA, Somannavar MS
     Pathophysiology and management of iron deficiency anaemia in pregnancy: a review.
     Ann Hematol. 2024;103:2637-2646.
     PubMed     Abstract available
     
     
     July 2024
130. MUSALLAM KM, Barella S, Origa R, Ferrero GB, et al
     Revisiting iron overload status and change thresholds as predictors of mortality in transfusion-dependent beta-thalassemia: a 10-year cohort study.
     Ann Hematol. 2024;103:2283-2297.
     PubMed     Abstract available
     
     
     
131. TER AVEST M, Langemeijer SMC, Blijlevens NMA, van de Kar NCAJ, et al
     Development of a target concentration intervention to individualize paroxysmal nocturnal hemoglobinuria treatment with pegcetacoplan.
     Ann Hematol. 2024;103:2267-2272.
     PubMed     Abstract available
     
     
     June 2024
132. GONG Y, Li Y, Chen X, Yang H, et al
     Refractory pure red cell aplasia associated with T-cell large granular lymphocyte leukemia treated by ruxolitinib.
     Ann Hematol. 2024 Jun 27. doi: 10.1007/s00277-024-05856.
     PubMed     Abstract available
     
     
     
133. WANG L, Fang L, Shi H, Liu Y, et al
     Treatment of myelofibrosis with refractory anemia with luspatercept: a multicenter Chinese study.
     Ann Hematol. 2024 Jun 22. doi: 10.1007/s00277-024-05847.
     PubMed     Abstract available
     
     
     
134. KANTER J, Ataga KI, Bhasin N, Guarino S, et al
     Expert consensus on the management of infusion-related reactions (IRRs) in patients with sickle cell disease (SCD) receiving crizanlizumab: a RAND/UCLA modified Delphi panel.
     Ann Hematol. 2024;103:1909-1917.
     PubMed     Abstract available
     
     
     
135. ZHANG Z, Hu Q, Yang C, Chen M, et al
     Comparison of human leukocyte antigen in patients with paroxysmal nocturnal hemoglobinuria of different clone sizes.
     Ann Hematol. 2024;103:1897-1907.
     PubMed     Abstract available
     
     
     
136. MELONI A, Pistoia L, Ricchi P, Bagnato S, et al
     Impact of genotype on multi-organ iron and complications in patients with non-transfusion-dependent beta-thalassemia intermedia.
     Ann Hematol. 2024;103:1887-1896.
     PubMed     Abstract available
     
     
     
137. YANG L, Niu H, Zhang T, Cao Q, et al
     A nomogram model for predicting the efficacy of cyclosporine in patients with pure red cell aplasia.
     Ann Hematol. 2024;103:1877-1885.
     PubMed     Abstract available
     
     
     
138. ALAYOUBI AM, Khawaji ZY, Mohammed MA, Mercier FE, et al
     CRISPR-Cas9 system: a novel and promising era of genotherapy for beta-hemoglobinopathies, hematological malignancy, and hemophilia.
     Ann Hematol. 2024;103:1805-1817.
     PubMed     Abstract available
     
     
     May 2024
139. SHI Y, Zhao Y, Liang W, Zhang B, et al
     A preliminary study of roxadustat in the treatment of aplastic anemia patients with inadequate erythroid responses.
     Ann Hematol. 2024 May 22. doi: 10.1007/s00277-024-05799.
     PubMed     Abstract available
     
     
     
140. NAKAMURA Y, Zaimoku Y, Yamaguchi H, Yamazaki H, et al
     Significance of absolute neutrophil count before allogeneic hematopoietic stem cell transplantation in adult patients with aplastic anemia.
     Ann Hematol. 2024 May 16. doi: 10.1007/s00277-024-05800.
     PubMed     Abstract available
     
     
     
141. BARDON-CANCHO EJ, Marco-Sanchez JM, Beneitez-Pastor D, Payan-Pernia S, et al
     Spanish registry of hemoglobinopathies and rare anemias (REHem-AR): demographics, complications, and management of patients with beta-thalassemia.
     Ann Hematol. 2024;103:1525-1539.
     PubMed     Abstract available
     
     
     
142. AL-KURAISHY HM, Mazhar Ashour MH, Saad HM, Batiha GE, et al
     COVID-19 and beta-thalassemia: in lieu of evidence and vague nexus.
     Ann Hematol. 2024;103:1423-1433.
     PubMed     Abstract available
     
     
     April 2024
143. HU M, Li J, Liu R, Zhang Z, et al
     Unrelated umbilical cord blood transplantation with low-dose anti-thymocyte globulin for children with severe aplastic anemia: A case series.
     Ann Hematol. 2024 Apr 24. doi: 10.1007/s00277-024-05756.
     PubMed     Abstract available
     
     
     
144. QIN S, Jiang Y, Ou Y, Zhan Y, et al
     Mendelian randomization of circulating proteome identifies IFN-gamma as a druggable target in aplastic anemia.
     Ann Hematol. 2024 Apr 22. doi: 10.1007/s00277-024-05746.
     PubMed     Abstract available
     
     
     
145. LOMMERSE IN, Hinnen C, van Vliet LM, Schubert B, et al
     Quality of life after immune suppressive therapy in aplastic anemia.
     Ann Hematol. 2024 Apr 5. doi: 10.1007/s00277-024-05731.
     PubMed     Abstract available
     
     
     
146. DE CASTRO JNP, da Silva Costa SM, Camargo ACL, Ito MT, et al
     Comparative transcriptomic analysis of circulating endothelial cells in sickle cell stroke.
     Ann Hematol. 2024;103:1167-1179.
     PubMed     Abstract available
     
     
     
147. SHARMA A, Kumar A, Saha PK, Saha L, et al
     The role of TMPRSS6 gene polymorphism in iron resistance iron deficiency anaemia (IRIDA): a systematic review.
     Ann Hematol. 2024;103:1085-1102.
     PubMed     Abstract available
     
     
     
148. WANG J, Zhu H, Miao K
     Gilteritinib combined with venetoclax and azacitidine for relapsed acute myeloid leukemia cocurrent with pure red cell aplasia after allogeneic hematopoietic stem cell transplantation: a case report.
     Ann Hematol. 2024 Apr 1. doi: 10.1007/s00277-024-05714.
     PubMed     Abstract available
     
     
     March 2024
149. VALLEJO C, Rosell A, Xicoy B, Garcia C, et al
     A multicentre ambispective observational study into the incidence and clinical management of aplastic anaemia in Spain (IMAS study).
     Ann Hematol. 2024;103:705-713.
     PubMed     Abstract available
     
     
     
150. LEONI S, Bou-Fakhredin R, Granata F, Cassinerio E, et al
     Acute liver injury after SARS-CoV-2 vaccination and luspatercept administration in a patient with beta-thalassemia.
     Ann Hematol. 2024;103:1025-1026.
     PubMed    
     
     
     February 2024
151. SECK M, Manal B, Toure SA, Keita M, et al
     Challenges in the management of iron-deficiency anemia in Senegal, West Africa.
     Ann Hematol. 2024 Feb 3. doi: 10.1007/s00277-024-05626.
     PubMed    
     
     
     
152. ZHA Q, Shi Y, Shi Z, Huang F, et al
     Loeys-Dietz syndrome with concomitant aplastic anemia.
     Ann Hematol. 2024 Feb 2. doi: 10.1007/s00277-024-05637.
     PubMed    
     
     
     
153. SONGDEJ D, Surapolchai P, Komwilaisak P, Sripornsawan P, et al
     Molecular characteristics of hereditary red blood cell membrane disorders in Thailand: a multi-center registry.
     Ann Hematol. 2024;103:385-393.
     PubMed     Abstract available
     
     
     
154. GARCIA-MORIN M, Bardon-Cancho EJ, Belendez C, Dulin E, et al
     Madrid Newborn Sickle Cell Disease Cohort: clinical outcomes, stroke prevention and survival.
     Ann Hematol. 2024;103:373-383.
     PubMed     Abstract available
     
     
     
155. MURAKHOVSKAYA I, Crivera C, Leon A, Alemao E, et al
     Healthcare resource utilization of patients with warm autoimmune hemolytic anemia initiating first line therapy of oral corticosteroids with or without rituximab.
     Ann Hematol. 2024 Feb 1. doi: 10.1007/s00277-023-05613.
     PubMed     Abstract available
     
     
     January 2024
156. CHATTOPADHYAY S, Lionel S, Selvarajan S, Devasia AJ, et al
     Relapse and transformation to myelodysplastic syndrome and acute myeloid leukemia following immunosuppressive therapy for aplastic anemia is more common as compared to allogeneic stem cell transplantation with a negative impact on survival.
     Ann Hematol. 2024 Jan 20. doi: 10.1007/s00277-024-05621.
     PubMed     Abstract available
     
     
     
157. ZHANG Z, Wang X, Jiang J
     Screening results and mutation frequency analysis of G6PD deficiency in 1,291,274 newborns in Huizhou, China: a twenty-year experience.
     Ann Hematol. 2024;103:29-36.
     PubMed     Abstract available
     
     
     
158. ZULLO A, De Francesco V, Gatta L, Scaccianoce G, et al
     Small bowel lesions in patients with iron deficiency anaemia without overt bleeding: a multicentre study.
     Ann Hematol. 2024;103:1-4.
     PubMed     Abstract available
     
     
     
159. SCHREZENMEIER H, Kulasekararaj A, Mitchell L, de Latour RP, et al
     Predictors for improvement in patient-reported outcomes: post hoc analysis of a phase 3 randomized, open-label study of eculizumab and ravulizumab in complement inhibitor-naive patients with paroxysmal nocturnal hemoglobinuria.
     Ann Hematol. 2024;103:5-15.
     PubMed     Abstract available
     
     
     December 2023
160. DELGADINHO M, Veiga L, Ginete C, Santos B, et al
     Differential expression of adhesion molecules in sickle cell anemia and gut microbiome effect.
     Ann Hematol. 2023 Dec 28. doi: 10.1007/s00277-023-05589.
     PubMed     Abstract available
     
     
     
161. FU L, Zhang J, Wang R, Yang B, et al
     Clinical characteristics of hepatitis-associated aplastic anemia in children.
     Ann Hematol. 2023 Dec 12. doi: 10.1007/s00277-023-05566.
     PubMed     Abstract available
     
     
     
162. MCBRIDE HJ, Frazer-Abel A, Thiemann S, Lehto SG, et al
     Functional similarity of ABP 959 and eculizumab in simulated serum models of aHUS and NMOSD.
     Ann Hematol. 2023;102:3299-3309.
     PubMed     Abstract available
     
     
     November 2023
163. GONG Y, Zhang X, Chen X, Yang H, et al
     Warm autoimmune hemolytic anemia associated with SARS-CoV-2 infection responsive to eculizumab.
     Ann Hematol. 2023 Nov 27. doi: 10.1007/s00277-023-05549.
     PubMed    
     
     
     
164. STRASSER B, Heibl S, Hormann G, Haushofer A, et al
     Diamond-Blackfan anemia with very late and fatal onset aplasia in a 55-year-old patient with RPL11 mutation.
     Ann Hematol. 2023 Nov 23. doi: 10.1007/s00277-023-05553.
     PubMed    
     
     
     
165. KITAMURA W, Kobayashi H, Iseki A, Wada H, et al
     Cold agglutinin-induced acrocyanosis without hemolytic anemia.
     Ann Hematol. 2023 Nov 9. doi: 10.1007/s00277-023-05538.
     PubMed    
     
     
     
166. POPE V, Hsia CC
     Safe utilization of ruxolitinib in simultaneous primary myelofibrosis and warm autoimmune hemolytic anemia.
     Ann Hematol. 2023 Nov 6. doi: 10.1007/s00277-023-05535.
     PubMed    
     
     
     
167. LOUZAO M, Vargas MT, Meseguer E, Pedrote Amador B, et al
     Successful use of thrombopoietin analogs in thrombocytopenia associated with MYH-9 mutation.
     Ann Hematol. 2023;102:3283-3284.
     PubMed    
     
     
     
168. SUN XH, Liu Q, Wu SN, Xu WH, et al
     Cytopenia: a report of haplo-cord transplantation in twin brothers caused by a novel germline GATA1 mutation and family survey.
     Ann Hematol. 2023;102:3177-3184.
     PubMed     Abstract available
     
     
     
169. VALLEE T, Schmid I, Gloning L, Bacova M, et al
     Excellent outcome of stem cell transplantation for sickle cell disease.
     Ann Hematol. 2023;102:3217-3227.
     PubMed     Abstract available
     
     
     
170. HOCHSMANN B, Peffault de Latour R, Hill A, Roth A, et al
     Risk factors for thromboembolic events in patients with paroxysmal nocturnal hemoglobinuria (PNH): a nested case-control study in the International PNH Registry.
     Ann Hematol. 2023;102:2979-2988.
     PubMed     Abstract available
     
     
     October 2023
171. SI T, Ma X, Zhu W, Zhou Y, et al
     Comment on: Association between anemia and depression: results from NHANES 2005-2018 and Mendelian randomization analyses.
     Ann Hematol. 2023 Oct 21. doi: 10.1007/s00277-023-05496.
     PubMed    
     
     
     
172. KURITA N, Nishikii H, Maruyama Y, Suehara Y, et al
     Safety of romiplostim administered immediately after cord-blood transplantation: a phase 1 trial.
     Ann Hematol. 2023;102:2895-2902.
     PubMed     Abstract available
     
     
     
173. DEENADAYALAN V, Litvin R, Vakil J, Kanemo P, et al
     Recent national trends in outcomes and economic disparities among adult sickle cell disease-related admissions.
     Ann Hematol. 2023;102:2659-2669.
     PubMed     Abstract available
     
     
     
174. ROCCOTELLI D, Grande D, Cicco G, Palma A, et al
     Real-life experience with luspatercept in transfusion-dependent beta-thalassemia.
     Ann Hematol. 2023;102:2965-2967.
     PubMed    
     
     
     
175. CAN F, Yilmaz KN, Kosemehmetoglu OS, Akinci S, et al
     Comparison of different intravenous iron preparations in terms of total oxidant and total antioxidant status, single center data.
     Ann Hematol. 2023;102:2645-2650.
     PubMed     Abstract available
     
     
     September 2023
176. YOUSSEF MAM, Ghazaly MH, Abdelfattah MA
     Alternative treatment modality for severe aplastic anemia in a resource-limited setting: a single-institution prospective cohort study from Upper Egypt.
     Ann Hematol. 2023 Sep 13. doi: 10.1007/s00277-023-05440.
     PubMed     Abstract available
     
     
     
177. CHEN M, Ataga KI, Hankins JS, Zhang M, et al
     Age-related differences in risks and outcomes of 30-day readmission in adults with sickle cell disease.
     Ann Hematol. 2023;102:2329-2342.
     PubMed     Abstract available
     
     
     
178. SHOME DK, Das P, Akbar GA, Taha S, et al
     Molecular insights into hereditary elliptocytosis and pyropoikilocytosis: NGS uncovers multiple potential candidate genes.
     Ann Hematol. 2023;102:2343-2351.
     PubMed     Abstract available
     
     
     
179. GREWAL US, Thotamgari SR, Gaddam SJ, Lakra R, et al
     Characteristics and outcomes associated with venous thrombotic complications among patients with paroxysmal nocturnal hemoglobinuria.
     Ann Hematol. 2023;102:2631-2632.
     PubMed    
     
     
     
180. HAYASHINO K, Fujiwara Y, Isokane Y, Tobita H, et al
     Paroxysmal nocturnal hemoglobinuria with ulcerative colitis.
     Ann Hematol. 2023;102:2625-2626.
     PubMed    
     
     
     August 2023
181. SORIN B, Fadlallah J, Garzaro M, Vigneron J, et al
     Real-life use of mTOR inhibitor-based therapy in adults with autoimmune cytopenia highlights strong efficacy in relapsing/refractory multi-lineage autoimmune cytopenia.
     Ann Hematol. 2023;102:2059-2068.
     PubMed     Abstract available
     
     
     
182. VIPRAKASIT V, Hamdy MM, Hassab HMA, Sherief LM, et al
     Patient preference for deferasirox film-coated versus dispersible tablet formulation: a sequential-design phase 2 study in patients with thalassemia.
     Ann Hematol. 2023;102:2039-2049.
     PubMed     Abstract available
     
     
     
183. MUSALLAM KM, Ahmed W, Almarshoodi MO, Trad O, et al
     Establishment of the Abu Dhabi Emirate Thalassemia Longitudinal Cohort (AD-TLC): leveraging the power of observation.
     Ann Hematol. 2023;102:2277-2278.
     PubMed    
     
     
     
184. SHIMAZU Y, Mizumoto C, Chonabayashi K, Hanyu Y, et al
     Successful treatment with cyclosporine of pure red cell aplasia induced by obinutuzumab bendamustine therapy.
     Ann Hematol. 2023;102:2291-2292.
     PubMed    
     
     
     July 2023
185. WANG Y, Guo D, Sui C, Qu Z, et al
     Association between anemia and depression: results from NHANES 2005-2018 and mendelian randomization analyses.
     Ann Hematol. 2023 Jul 22. doi: 10.1007/s00277-023-05374.
     PubMed     Abstract available
     
     
     
186. HAMMAMI MB, Qasim A, Thakur R, Vegivinti CTR, et al
     Rasburicase-induced hemolytic anemia and methemoglobinemia: a systematic review of current reports.
     Ann Hematol. 2023 Jul 19. doi: 10.1007/s00277-023-05364.
     PubMed     Abstract available
     
     
     
187. LIN F, Dong X, Zhang Y, Cheng Y, et al
     Time-dependent analysis of the impact on early cytomegalovirus reactivation of HLA mismatch and acute graft-versus-host disease after allogeneic hematopoietic cell transplantation from related donors in acquired aplastic anemia.
     Ann Hematol. 2023 Jul 13. doi: 10.1007/s00277-023-05332.
     PubMed     Abstract available
     
     
     
188. ZHAO J, Ma L, Zheng M, Su L, et al
     Meta-analysis of the results of haploidentical transplantation in the treatment of aplastic anemia.
     Ann Hematol. 2023 Jul 13. doi: 10.1007/s00277-023-05339.
     PubMed     Abstract available
     
     
     
189. BODLA ZH, Hashmi M, Niaz F, Farooq U, et al
     Timing matters: An analysis of the relationship between red cell transfusion timing and hospitalization outcomes in sickle cell crisis patients using the National Inpatient Sample database.
     Ann Hematol. 2023;102:1669-1676.
     PubMed     Abstract available
     
     
     
190. DINGLI D, Maciejewski JP, Larratt L, Go RS, et al
     Relationship of paroxysmal nocturnal hemoglobinuria (PNH) granulocyte clone size to disease burden and risk of major vascular events in untreated patients: results from the International PNH Registry.
     Ann Hematol. 2023;102:1637-1644.
     PubMed     Abstract available
     
     
     
191. AU TY, Wisniewski OW, Benjamin S, Kubicki T, et al
     G6PD deficiency-does it alter the course of COVID-19 infections?
     Ann Hematol. 2023;102:1629-1636.
     PubMed     Abstract available
     
     
     June 2023
192. CANNAS G, Poutrel S, Heiblig M, Labussiere H, et al
     Sickle cell disease and acute leukemia: one case report and an extensive review.
     Ann Hematol. 2023 Jun 3:1-11. doi: 10.1007/s00277-023-05294.
     PubMed     Abstract available
     
     
     May 2023
193. ARAUJO COSTA E, de Paula Ayres-Silva J
     Global profile of anemia during pregnancy versus country income overview: 19 years estimative (2000-2019).
     Ann Hematol. 2023 May 26. doi: 10.1007/s00277-023-05279.
     PubMed     Abstract available
     
     
     
194. WU LQ, Huang LF, Yang H, Ye BD, et al
     Comparison of haploidentical-allogeneic hematopoietic stem cell transplantation and intensive immunosuppressive therapy for patients with severe aplastic anemia with an absolute neutrophil count of zero: a retrospective study.
     Ann Hematol. 2023 May 17. doi: 10.1007/s00277-023-05256.
     PubMed     Abstract available
     
     
     
195. NIU H, Yan L, Yang L, Zhang M, et al
     High TOX expression on CD8(+) T cells in pure red cell aplasia.
     Ann Hematol. 2023;102:1247-1255.
     PubMed     Abstract available
     
     
     
196. DONGERDIYE R, Bokde M, More TA, Saptarshi A, et al
     Targeted next-generation sequencing identifies eighteen novel mutations expanding the molecular and clinical spectrum of PKLR gene disorders in the Indian population.
     Ann Hematol. 2023;102:1029-1036.
     PubMed     Abstract available
     
     
     
197. BELISARIO AR, Simoes E Silva AC, Moura ICG, Carneiro-Proietti AB, et al
     Estimated glomerular filtration rate in Brazilian adults with sickle cell disease: results from the REDS-III multicenter cohort study.
     Ann Hematol. 2023;102:1019-1027.
     PubMed     Abstract available
     
     
     April 2023
198. ABDEL-SALAM A, Bassiouni ST, Goher AM, Shafie ES, et al
     Autoimmune Hemolytic Anemia in the Pediatric Age Group: The Egyptian Experience.
     Ann Hematol. 2023 Apr 24. doi: 10.1007/s00277-023-05230.
     PubMed     Abstract available
     
     
     
199. TSILIKA M, Mitrou J, Antonakos N, Tseti IK, et al
     An active new formulation of iron carried by aspartyl casein for iron-deficiency anemia: results of the ACCESS trial.
     Ann Hematol. 2023 Apr 6. doi: 10.1007/s00277-023-05197.
     PubMed     Abstract available
     
     
     
200. JONGKRAIJAKRA S, Doungngern T, Sripakdee W, Lekhakula A, et al
     A randomized controlled trial of thrice-weekly versus thrice-daily oral ferrous fumarate treatment in adult patients with iron-deficiency anemia.
     Ann Hematol. 2023 Apr 3:1-8. doi: 10.1007/s00277-023-05198.
     PubMed     Abstract available
     
     
     
201. IGLESIAS-VAZQUEZ L, Gimeno M, Coronel P, Caspersen IH, et al
     Maternal factors associated with iron deficiency without anaemia in early pregnancy: ECLIPSES study.
     Ann Hematol. 2023;102:741-748.
     PubMed     Abstract available
     
     
     
202. ZHANG Y, Pan J, Kang H, Peng S, et al
     Characteristics of inpatients with newly diagnosed multiple myeloma in hematology, nephrology, and orthopedic departments.
     Ann Hematol. 2023;102:801-809.
     PubMed     Abstract available
     
     
     March 2023
203. YANG K, Nie W, Huang Q, Liao G, et al
     Hematopoietic cell transplantation for congenital dyserythropoietic anemia IV caused by compound heterozygous KLF1 mutations.
     Ann Hematol. 2023 Mar 31. doi: 10.1007/s00277-023-05175.
     PubMed    
     
     
     
204. DING K, Liu Z, Ren Y, Liu H, et al
     Use of roxadustat (FG-4592) in ruxolitinib-treatment-related anemia of two myelofibrosis patients.
     Ann Hematol. 2023 Mar 13. doi: 10.1007/s00277-022-04997.
     PubMed    
     
     
     
205. AHMADI M, Beiranvand S, Poormansouri S, Matbouei M, et al
     Sense of coherence or self-efficacy as predictors of health-related quality of life in sickle cell disease patients.
     Ann Hematol. 2023;102:519-528.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Anemia is free of charge.